Electrum Numb Foam

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Electrum Numb Foam
Generic name: LIDOCAINE HCI
Manufacturer: RENU LABORATORIES, LLC
Product type: HUMAN OTC DRUG
SPL set ID: c8472932-28b7-9189-e053-2a95a90a44df
SPL ID: 33a12d5b-1eac-7b76-e063-6294a90a04eb
Version: 6
Effective date: 2025-04-25
Source export date: 2026-09-28
Source partition: 9
Source file: https://download.open.fda.gov/drug/label/drug-label-0009-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/6784607726c827491ceaeab30d843632e0660ee8008c535197be5ed9e1e52201/drug-label-0009-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 06:04:44

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M017	openfda.application_number
brand name		Electrum Numb Foam	openfda.brand_name
generic name		LIDOCAINE HCI	openfda.generic_name
manufacturer name		RENU LABORATORIES, LLC	openfda.manufacturer_name
ndc	package	76348-596-17	openfda.package_ndc
ndc	product	76348-596	openfda.product_ndc
ndc11	package	76348059617	derived:openfda.package_ndc
rxcui		2604567	openfda.rxcui
spl id		33a12d5b-1eac-7b76-e063-6294a90a04eb	id
spl set id		c8472932-28b7-9189-e053-2a95a90a44df	set_id
unii		V13007Z41A	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

For external use only avoid contact with eyes do not exceed recommended dosage unless directed by a doctor Do not use in the eyes or apply to large areas of body longer than 1 week unless directed by a doctor in large quantities particularly over raw surfaces or blistered areas ask a doctor before use if you have deep or puncture wounds, animal bites, or serious burns

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.